The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Body composition measurements and overall survival in patients with resectable pancreatic adenocarcinoma receiving neoadjuvant chemotherapy: Analysis from SWOG S1505.
 
Davendra Sohal
Honoraria - Foundation Medicine
Consulting or Advisory Role - Ability Pharma; Perthera
Speakers' Bureau - Incyte
Research Funding - Amgen (Inst); Apexigen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Incyte (Inst); Rafael Pharmaceuticals (Inst)
 
Mai T. Duong
No Relationships to Disclose
 
Robert Boutin
No Relationships to Disclose
 
Leon Lenchik
No Relationships to Disclose
 
Jiyoon Kim
No Relationships to Disclose
 
Namita Gandhi
No Relationships to Disclose
 
Muhammad Shaalan Beg
Consulting or Advisory Role - Array BioPharma; AstraZeneca/MedImmune; Cancer Commons; Ipsen; Legend Biotech
Research Funding - Agios (Inst); ArQule (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); CASI Pharmaceuticals (Inst); Celgene (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); ImmuneSensor Therapeutics (Inst); MedImmune (Inst); Merck Serono (Inst); Sillajen (Inst); Tolero Pharmaceuticals (Inst)
 
Andrea Wang-Gillam
Employment - Jacobio
Stock and Other Ownership Interests - Jacobio
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai; Inxmed; Inxmed; Jacobio; Merck; Repugene; Tyme
Research Funding - AstraZeneca (Inst); BioMed Valley Discoveries (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); CTI (Inst); Gossamer Bio (Inst); Hutchison MediPharma (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Newlink Genetics (Inst); pfizer (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Verastem (Inst); Xcovery (Inst)
 
James Lloyd Wade
Employment - Johnson & Johnson (I)
Stock and Other Ownership Interests - Abbott (I); Celgene; GlaxoSmithKline (I); Johnson & Johnson (I); Novartis (I)
Consulting or Advisory Role - New Century Health
 
Katherine A Guthrie
No Relationships to Disclose
 
Elena Gabriela Chiorean
Consulting or Advisory Role - Bayer; BioNTech; BioNTech; Celgene; Ipsen; Legend Biotech; Noxxon Pharma; Pfizer; SOBI
Research Funding - AADi (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Corcept Therapeutics (Inst); FibroGen; Halozyme (Inst); Ignyta (Inst); Incyte (Inst); Lilly (Inst); MacroGenics (Inst); Merck (Inst); Rafael Pharmaceuticals (Inst); Stemline Therapeutics (Inst)
Travel, Accommodations, Expenses - Ipsen; Legend Biotech
 
Syed A. Ahmad
No Relationships to Disclose
 
Andrew M. Lowy
Consulting or Advisory Role - Fount Therapeutics; Halozyme; HUYA Bioscience International; Merck; PFizer; Rafael Pharmaceuticals
Research Funding - Mitsubishi Tanabe Pharma; Syros Pharmaceuticals
Expert Testimony - Merck
Travel, Accommodations, Expenses - Pfizer
 
Howard S. Hochster
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Elion Oncology; Genentech; Merck
 
Philip Agop Philip
Honoraria - Array BioPharma; AstraZeneca; Bayer; Blueprint Medicines; Celgene; Ipsen; Merck; SynCoreBio; TriSalus Life Sciences
Consulting or Advisory Role - Celgene; Daiichi Sankyo; Ipsen; Merck; SynCoreBio; Taiho Pharmaceutical; TriSalus Life Sciences
Speakers' Bureau - Bayer; Celgene; Incyte; Ipsen; Novartis
Research Funding - Advanced Accelerator Applications (Inst); ASLAN Pharmaceuticals (Inst); Bayer (Inst); boston biomedical (Inst); Caris Life Sciences (Inst); Caris Life Sciences (Inst); Genentech (Inst); halozyme (Inst); Immunomedics (Inst); incyte (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck (Inst); merus (Inst); Momenta Pharmaceuticals (Inst); novartis (Inst); Plexxikon (Inst); QED Therapeutics (Inst); QED Therapeutics (Inst); Regeneron (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); TYME (Inst); tyme (Inst)
Travel, Accommodations, Expenses - Abbvie; celgene; Rafael Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Caris MPI; Rafael Pharmaceuticals
 
Victor Tsu-Shih Chang
Research Funding - Incyte (Inst)